SIA
ABMD

Schechter Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Schechter Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,059
Closed -$505K – 995
2022
Q3 		$505K Buy
2,059
+9
+0.4% +$2.43K 0.05% 508
2022
Q2 		$507K Sell
2,050
-47
-2% -$12.7K 0.05% 524
2022
Q1 		$694K Sell
2,097
-270
-11% -$83.1K 0.06% 428
2021
Q4 		$851K Buy
+2,367
New +$800K 0.08% 366

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schechter Investment Advisors's ABMD Position: Q4 2022 in Review

Schechter Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,059 shares — an estimated $505K sold.

Schechter Investment Advisors first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $851K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Schechter Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Schechter Investment Advisors sold 2,059 Abiomed Inc shares in Q4 2022, an estimated $505K.
  • Schechter Investment Advisors first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
  • Schechter Investment Advisors's Abiomed Inc position peaked at $851K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Schechter Investment Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.